Clinical Focus

• Inflammatory Bowel Diseases
• Gastroenterology

Administrative Appointments

• Clinical Director, Inflammatory Bowel Disease Program, Division of Gastroenterology (2008 - present)

Honors and Awards

• Member, Alpha Omega Alpha Honor Medical Society (2000)
• Intern of the Year, Charity Hospital, New Orleans (2001)
• Intern, Teaching Excellence Award (2001)
• Resident, Teaching Award (2004)

Professional Education

Graduate & Fellowship Program Affiliations

• Medicine

Current Research Interests

I joined Stanford after specialized training in Crohn's disease and ulcerative colitis. I am the Clinical Director of the Inflammatory Bowel Disease Program. My clinical and research interests within IBD include the application of novel diagnostic tools, study of IBD-associated conditions, treatment of severe colitis, and prevention of post-operative recurrence.

Publications

• Atypical rectal bleeding: the challenge of diagnosing mild ulcerative colitis. Levesque BG, Pai R, Shah SB. Dig Dis Sci. 2010; 55 (3): 586-8
• Risks and benefits of the use of concomitant immunosuppressives and biologics in inflammatory bowel disease. Shah SB, Hanauer SB. Rev Gastroenterol Disord. 2008; 8 (3): 159-68
• Intravenous cyclosporin in severe steroid-refractory ulcerative colitis: Long-term follow-up Shah SB, Parekh NK, Hanauer SB, Cohen RD. Oral presentation DDW 2008. 2008; 134 (4)
• Treatment of diarrhea in patients with inflammatory bowel disease: concepts and cautions. Shah SB, Hanauer SB. Rev Gastroenterol Disord. 2007: 7 Suppl 3 S3-10